| ［1］ |
Jemal A，Siegel R，Ward E，et al.Cancer statistics，2006［J］.CA Cancer J Clin，2006，56（2）：106-130.
|
| ［2］ |
Swerdlow AJ，Schoemaker MJ，Higgins CD，et al.Cancer incidence and mortality in men with Klinefelter syndrome：a cohort study［J］.J Natl Cancer Inst，2005，97（16）：1204-1210.
|
| ［3］ |
Koc M，Polat P.Epidemiology and aetiological factors of male breast cancer：a ten years retrospective study in eastern Turkey［J］.Eur J Cancer Prev，2001，10（6）：531-534.
|
| ［4］ |
Ron E，Ikeda T，Preston DL，et al.Male breast cancer incidence among atomic bomb survivors［J］.J Natl Cancer Inst，2005，97（8）：603-605.
|
| ［5］ |
Chodick G，Struewing JP，Ron E，et al.Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer：evidence from 261 cases in Israel，1976-1999［J］.Eur J Med Genet，2008，51（2）：141-147.
|
| ［6］ |
Schlebusch CM，Dreyer G，Sluiter MD，et al.Cancer prevalence in 129 breast-ovarian cancer families tested for BRCA1 and BRCA2 mutations［J］.S Afr Med J，2010，100（2）：113-117.
|
| ［7］ |
Liukkonen S，Saarto T，Maenpaa H，et al.Male breast cancer：a survey at the Helsinki University Central Hospital during 1981-2006［J］.Acta Oncol，2010，49（3）：322-327.
|
| ［8］ |
Brenner B，Fried G，Levitzki P，et al.Male breast carcinoma in Israel：higher incident but possibly prognosis in Ashkenazi Jews［J］.Cancer，2002，94（8）：2128-2133.
|
| ［9］ |
Zhou FF，Xia LP，Guo GF，et al.Changes in therapeutic strategies in Chinese male patients with breast cancer：40 years of experience in a single institute［J］.Breast，2010，19（6）：450-455.
|
| ［10］ |
Pant I，Joshi SC.Invasive papillary carcinoma of the male breast：report of a rare case and review of the literature［J］.J Cancer Res Ther，2009，5（3）：216-218.
|
| ［11］ |
Park S，Kim JH，Koo J，et al.Clinicopathological characteristics of male breast cancer［J］.Yonsei Med J，2008，49（6）：978-986.
|
| ［12］ |
Murphy CE，Carder PJ，Lansdown MR，et al.Steroid hormone receptor expression in male breast cancer［J］.Eur J Surg Oncol，2006，32（1）：44-47.
|
| ［13］ |
Erdem O，Dursun A，Coskun U，et al.The prognostic value of p53 and c-erbB-2 expression，proliferative activity and angiogenesis in node-negative breast carcinoma［J］.Tumori，2005，91（1）：46-52.
|
| ［14］ |
Hu SW，Chuang JH，Tsai KB.Immunohistochemical expression in male breast cancer：two case reports［J］.Kaohsiung J Med Sci，2006，22（5）：235-242.
|
| ［15］ |
Gennari R，Curigliano G，Jereczek-Fossa BA，et al.Male breast cancer：a special therapeutic problem.Anything new［J］？Int J Oncol，2004，24（3）：663-670.
|
| ［16］ |
Gentilini O，Chagas E，Zurrida S，et al.Sentinel lymph node biopsy in male patients with early breast cancer［J］.Oncologist，2007，12（5）：512-515.
|
| ［17］ |
Malani AK.Male breast cancer：a different disease than female breast cancer？［J］.South Med J，2007，100（2）：197.
|
| ［18］ |
Sosnovskikh I，Naninato P，Gatti G，et al.Synchronous bilateral breast cancer in men：a case report and review of the literature［J］.Tumori，2007，93（2）：225-227.
|
| ［19］ |
Ahmed R，Ali SM.Role of imaging in diagnosis of carcinoma of breast［J］.J Coll Physicians Surg Pak，2005，15（4）：238-241.
|
| ［20］ |
Hines SL，Tan WW，Yasrebi M，et al.The role of mammography in male patients with breast symptoms［J］.Mayo Clin Proc，2007，82（3）：297-300.
|
| ［21］ |
Hanavadi S，Monypenny IJ，Mansel RE.Is mammography overused in male patients？［J］.Breast，2006，15（1）：123-126.
|
| ［22］ |
Wauters CA，Kooistra BW，de Kievit-van der Heijden IM，et al.Is cytology useful in the diagnostic workup of male breast lesions？A retrospective study over a 16-year period and review of the recent literature［J］.Acta Cytol，2010，54（3）：259-264.
|
| ［23］ |
Zhou FF，Xia LP，Guo GF，et al.Changes in therapeutic strategies in Chinese male patients with breast cancer：40 years of experience in a single institute［J］.Breast，2010，19（6）：450-455.
|
| ［24］ |
Goss PE，Reid C，Pintilie M，et al.Male breast carcinoma：a review of 229 patients who presented to the Princess Margaret Hospital during 40 years：1955-1996［J］.Cancer，1999，85（3）：629-639.
|
| ［25］ |
Wang J，Kollias J，Marsh C，et al.Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand？［J］.Breast，2009，18（6）：378-381.
|
| ［26］ |
Santeufemia DA，Capobianco G，Dessole S，et al.Tamoxifen induced severe hypertriglyceridemia in a male patient with breast carcinoma［J］.Breast J，2009，15（6）：675-676.
|
| ［27］ |
Cutuli B，Le-Nir CC，Serin D，et al.Male breast cancer.Evolution of treatment and prognostic factors.Analysis of 489 cases［J］.Crit Rev Oncol Hematol，2010，73（3）：246-254.
|
| ［28］ |
El-Tamer MB，Komenaka IK，Troxel A，et al.Men with breast cancer have better disease-specific survival than women［J］.Arch Surg，2004，139（10）：1079-1082.
|
| ［29］ |
Arriola E，Hui E，Dowsett M，et al.Aromatase inhibitors and male breast cancer［J］.Clin Transl Oncol，2007，9（3）：192-194.
|
| ［30］ |
Giordano SH，Cohen DS，Buzdar AU，et al.Breast carcinoma in men：a population-based study［J］.Cancer，2004，101（1）：51-57.
|
| ［31］ |
Truong PT，Berthelet E，Lee J，et al.The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes［J］.Cancer，2005，103（10）：2006-2014.
|